SCHEMBL19634057

SCHEMBL19634057

COc1ccc(CN(Sc2c(F)cc(F)c(Cl)c2F)c2ncns2)c(OC)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.34
CYP1A2 P05177 9/20 0.33
CYP3A4 P08684 9/20 0.33
CYP2D6 P10635 9/20 0.33
CYP2C19 P33261 8/20 0.33
TSHR P16473 8/20 0.33
ALDH1A1 P00352 4/20 0.33
CLK4 Q9HAZ1 4/20 0.33
MAPK1 P28482 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
HSD17B10 Q99714 2/20 0.33
CYP2C9 P11712 2/20 0.33
HIF1A Q16665 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
POLB P06746 1/20 0.33
HTR2A P28223 1/20 0.33
SLC6A4 P31645 1/20 0.33
KCNH2 Q12809 1/20 0.33
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19634236 0.90 KDM4E (0.35) KDM4ECYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL19634002 0.89 DHFR (0.34) KDM4ECYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL19634121 0.85 MEN1 (0.36) KDM4ECYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL26184797 0.84 HTR2A (0.38) KDM4ECYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL19633950 0.84 TSHR (0.33) KDM4ECYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL19001230 0.84 KDM4E (0.35) KDM4ECYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL20256889 0.81 CYP1A2 (0.37) KDM4ECYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL22089038 0.81 HTR2A (0.36) KDM4ECYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL20256918 0.81 SCN1A (0.51) KDM4ECYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL22087758 0.80 POLB (0.35) KDM4ECYP1A2CYP3A4CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017201468-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2017-11-23 WO disclosed